Bender Jeremy
SEC Form 4 insider trading activity
Bender Jeremy has filed 5 SEC Form 4 filings (24 transaction rows) across 2 companies, including AURA, DAWN, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Jul 8, 2026.
On the most recent filing, Bender Jeremy is listed as CHIEF EXECUTIVE OFFICER at Day One Biopharmaceuticals, Inc. Inside the rolling window, Bender Jeremy reported no open-market purchases and 2 open-market sales totaling $321K in DAWN. The largest disclosed transaction in the window is a sale of 15,459 DAWN shares on Feb 17, 2026, worth $179K.
Companies traded
Other insiders at AURA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$321K
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Bender Jeremy made?
Bender Jeremy has filed 5 SEC Form 4 filings (24 transaction rows) across 2 companies, including AURA, DAWN since 2025.
Which companies does Bender Jeremy trade?
Bender Jeremy has filed SEC Form 4 disclosures for 2 companies, including AURA, DAWN.
When was Bender Jeremy's most recent SEC Form 4 filing?
Bender Jeremy's most recent SEC Form 4 filing on Tracefour is dated Jul 8, 2026.
What is Bender Jeremy's total buy and sell value in the current window?
Inside the rolling retention window, Bender Jeremy bought $0 and sold $321K based on SEC Form 4 filings.
What was Bender Jeremy's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 15,459 DAWN shares on 2026-02-17, worth $179K, per SEC Form 4 filings.